Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program

NCT02251938 is registered in ClinicalTrials.gov with Santen Inc. as lead sponsor.

NCT NCT02251938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02251938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Lead sponsor
Santen Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 29, 2014
Completion date
November 27, 2017
Enrollment
60 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

non-infectious uveitis of the posterior segment of the eye